uniQure Ownership | Who Owns uniQure?
uniQure Ownership Summary
uniQure is owned by 96.60% institutional investors, 6.08% insiders. Rtw investments, lp is the largest institutional shareholder, holding 9.41% of QURE shares. abrdn Healthcare Investors is the top mutual fund, with 2.79% of its assets in uniQure shares.
QURE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | uniQure | 96.60% | 6.08% | -2.68% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 5.16M | 9.41% | $71.91M |
| Ecor1 capital | 3.40M | 6.98% | $60.04M |
| Vestal point capital, lp | 3.70M | 6.75% | $51.58M |
| Avoro capital advisors | 3.63M | 6.61% | $50.53M |
| Abrdn | 2.75M | 5.02% | $38.34M |
| Franklin resources | 1.99M | 4.08% | $35.10M |
| Blackrock | 1.93M | 3.98% | $8.63M |
| Jefferies financial group | 2.10M | 3.82% | $29.22M |
| Nantahala capital management | 2.05M | 3.74% | $28.60M |
| Sofinnova investments | 1.56M | 2.84% | $21.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vestal point capital, lp | 3.70M | 2.72% | $51.58M |
| Stempoint capital lp | 572.62K | 2.56% | $7.98M |
| Ecor1 capital | 3.40M | 2.27% | $60.04M |
| Integral health asset management | 1.35M | 1.72% | $18.82M |
| Birchview capital, lp | 98.70K | 1.37% | $1.38M |
| Sofinnova investments | 1.56M | 1.33% | $21.72M |
| 683 capital management | 1.28M | 1.18% | $17.91M |
| Nantahala capital management | 2.05M | 1.12% | $28.60M |
| Rtw investments, lp | 5.16M | 1.02% | $71.91M |
| Avoro capital advisors | 3.63M | 0.88% | $50.53M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | 3.40M | 2.27% | 3.40M |
| Jefferies financial group | 2.10M | 0.25% | 2.10M |
| Avoro capital advisors | 3.63M | 0.88% | 1.45M |
| Sofinnova investments | 1.56M | 1.33% | 1.01M |
| Rtw investments, lp | 5.16M | 1.02% | 892.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 3.70M | 2.72% | -1.09M |
| Nantahala capital management | 2.05M | 1.12% | -704.11K |
| Voloridge investment management | - | - | -500.98K |
| Schroder investment management group | 693.28K | 0.01% | -496.84K |
| Alphacentric advisors | - | - | -460.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ecor1 capital | 3.40M | 2.27% | 3.40M | $60.04M |
| Jefferies financial group | 2.10M | 0.25% | 2.10M | $29.22M |
| Norges bank | 207.10K | 0.00% | 207.10K | $927.81K |
| Woodline partners lp | 140.63K | 0.02% | 140.63K | $2.48M |
| Jennison associates | 140.06K | 0.00% | 140.06K | $1.95M |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -1.00 |
| Gamma investing | -20.00 |
| Nelson, van denburg & campbell wealth management group | -32.00 |
| Pineridge advisors | -38.00 |
| Physician wealth advisors | -47.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 170 | 3.66% | 52,946,969 | 5.89% | 96 | 1.09% | 75 | 2.74% | 54 | 31.71% |
| Mar 31, 2025 | 23 | -85.35% | 19,779,316 | -52.46% | 37 | 0.51% | 14 | -81.08% | 5 | -89.36% |
| Dec 31, 2024 | 148 | 4.23% | 38,592,241 | -0.74% | 79 | 1.24% | 68 | -2.86% | 45 | 21.62% |
| Sep 30, 2024 | 141 | 9.30% | 38,878,066 | 22.43% | 79 | 1.85% | 69 | 23.21% | 37 | - |
| Jun 30, 2024 | 129 | -6.52% | 31,756,298 | -1.57% | 65 | 1.44% | 56 | -22.22% | 37 | 15.63% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| abrdn Healthcare Investors | 1.53M | 2.79% | 111.67K |
| Franklin Biotechnology Discv A(acc)USD | 1.04M | 1.89% | - |
| JPMorgan Small Cap Growth A | 891.96K | 1.63% | 891.96K |
| SPDR® S&P Biotech ETF | 833.80K | 1.52% | 20.57K |
| Delaware Healthcare I | 706.17K | 1.45% | - |
| abrdn World Healthcare | 736.66K | 1.34% | 59.32K |
| Macquarie Healthcare I | 706.17K | 1.29% | - |
| abrdn Life Sciences Investors | 704.74K | 1.28% | 50.00K |
| Franklin Biotechnology Discovery A | 568.80K | 1.04% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 550.98K | 1.00% | -241.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 27, 2025 | Abi-Saab Walid | Chief Medical Officer | Sell | $20.41K |
| Jun 20, 2025 | Springhorn Jeremy P. | - | Sell | $30.52K |
| Jun 20, 2025 | POST LEONARD E | - | Sell | $30.52K |
| Jun 20, 2025 | Kaye Jack | - | Sell | $30.52K |
| Jun 20, 2025 | Jacques Rachelle Suzanne | - | Sell | $30.52K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | 3 |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | 3 |
QURE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools